English
Segment disclosures
Company overviewCAREFUSION CORP
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Sales Revenue Segment · Dispensing Technologies · Medical Systems
Concentration Risk By Benchmark · Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesRevenueSegmentMember;us-gaap:ProductOrServiceAxis=cfn:DispensingTechnologiesMember;us-gaap:StatementBusinessSegmentsAxis=cfn:MedicalSystemsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2013-07-01 – 2013-09-30 | 211000000 | USD | 20131210 | Open filing evidence |
| 2012-07-01 – 2013-06-30 | 993000000 | USD | 20131210 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 244000000 | USD | 20131210 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 1038000000 | USD | 20131210 | Open filing evidence |
| 2010-07-01 – 2011-06-30 | 910000000 | USD | 20131210 | Open filing evidence |
Sales Revenue Segment · Infection Prevention · Procedural Solutions
Concentration Risk By Benchmark · Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesRevenueSegmentMember;us-gaap:ProductOrServiceAxis=cfn:InfectionPreventionMember;us-gaap:StatementBusinessSegmentsAxis=cfn:ProceduralSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2013-07-01 – 2013-09-30 | 149000000 | USD | 20131210 | Open filing evidence |
| 2012-07-01 – 2013-06-30 | 594000000 | USD | 20131210 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 144000000 | USD | 20131210 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 576000000 | USD | 20131210 | Open filing evidence |
| 2010-07-01 – 2011-06-30 | 568000000 | USD | 20131210 | Open filing evidence |
Sales Revenue Segment · Infusion Systems · Medical Systems
Concentration Risk By Benchmark · Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesRevenueSegmentMember;us-gaap:ProductOrServiceAxis=cfn:InfusionSystemsMember;us-gaap:StatementBusinessSegmentsAxis=cfn:MedicalSystemsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2013-07-01 – 2013-09-30 | 219000000 | USD | 20131210 | Open filing evidence |
| 2012-07-01 – 2013-06-30 | 916000000 | USD | 20131210 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 203000000 | USD | 20131210 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 955000000 | USD | 20131210 | Open filing evidence |
| 2010-07-01 – 2011-06-30 | 889000000 | USD | 20131210 | Open filing evidence |
Sales Revenue Segment · Medical Specialties · Procedural Solutions
Concentration Risk By Benchmark · Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesRevenueSegmentMember;us-gaap:ProductOrServiceAxis=cfn:MedicalSpecialtiesMember;us-gaap:StatementBusinessSegmentsAxis=cfn:ProceduralSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2013-07-01 – 2013-09-30 | 89000000 | USD | 20131210 | Open filing evidence |
| 2012-07-01 – 2013-06-30 | 344000000 | USD | 20131210 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 80000000 | USD | 20131210 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 317000000 | USD | 20131210 | Open filing evidence |
| 2010-07-01 – 2011-06-30 | 322000000 | USD | 20131210 | Open filing evidence |
Sales Revenue Segment · Other Medical Systems · Medical Systems
Concentration Risk By Benchmark · Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesRevenueSegmentMember;us-gaap:ProductOrServiceAxis=cfn:OtherMedicalSystemsMember;us-gaap:StatementBusinessSegmentsAxis=cfn:MedicalSystemsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2013-07-01 – 2013-09-30 | 6000000 | USD | 20131210 | Open filing evidence |
| 2012-07-01 – 2013-06-30 | 27000000 | USD | 20131210 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 7000000 | USD | 20131210 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 26000000 | USD | 20131210 | Open filing evidence |
| 2010-07-01 – 2011-06-30 | 24000000 | USD | 20131210 | Open filing evidence |
Sales Revenue Segment · Other Procedural Solutions · Procedural Solutions
Concentration Risk By Benchmark · Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesRevenueSegmentMember;us-gaap:ProductOrServiceAxis=cfn:OtherProceduralSolutionsMember;us-gaap:StatementBusinessSegmentsAxis=cfn:ProceduralSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2010-07-01 – 2011-06-30 | 32000000 | USD | 20131210 | Open filing evidence |
Sales Revenue Segment · Respiratory Technologies · Medical Systems
Concentration Risk By Benchmark · Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesRevenueSegmentMember;us-gaap:ProductOrServiceAxis=cfn:RespiratoryTechnologiesMember;us-gaap:StatementBusinessSegmentsAxis=cfn:MedicalSystemsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2013-07-01 – 2013-09-30 | 88000000 | USD | 20131210 | Open filing evidence |
| 2012-07-01 – 2013-06-30 | 393000000 | USD | 20131210 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 97000000 | USD | 20131210 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 420000000 | USD | 20131210 | Open filing evidence |
| 2010-07-01 – 2011-06-30 | 391000000 | USD | 20131210 | Open filing evidence |
Sales Revenue Segment · Specialty Disposables · Procedural Solutions
Concentration Risk By Benchmark · Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesRevenueSegmentMember;us-gaap:ProductOrServiceAxis=cfn:SpecialtyDisposablesMember;us-gaap:StatementBusinessSegmentsAxis=cfn:ProceduralSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2013-07-01 – 2013-09-30 | 68000000 | USD | 20131210 | Open filing evidence |
| 2012-07-01 – 2013-06-30 | 283000000 | USD | 20131210 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 62000000 | USD | 20131210 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 266000000 | USD | 20131210 | Open filing evidence |
| 2010-07-01 – 2011-06-30 | 304000000 | USD | 20131210 | Open filing evidence |
Sales Revenue Segment · Medical Systems
Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesRevenueSegmentMember;us-gaap:StatementBusinessSegmentsAxis=cfn:MedicalSystemsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2013-07-01 – 2013-09-30 | 524000000 | USD | 20131210 | Open filing evidence |
| 2012-07-01 – 2013-06-30 | 2329000000 | USD | 20131210 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 551000000 | USD | 20131210 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 2439000000 | USD | 20131210 | Open filing evidence |
| 2010-07-01 – 2011-06-30 | 2214000000 | USD | 20131210 | Open filing evidence |
Sales Revenue Segment · Procedural Solutions
Concentration Risk By Benchmark · Statement Business Segments
Source dimensions
us-gaap:ConcentrationRiskByBenchmarkAxis=us-gaap:SalesRevenueSegmentMember;us-gaap:StatementBusinessSegmentsAxis=cfn:ProceduralSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2013-07-01 – 2013-09-30 | 306000000 | USD | 20131210 | Open filing evidence |
| 2012-07-01 – 2013-06-30 | 1221000000 | USD | 20131210 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 286000000 | USD | 20131210 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 1159000000 | USD | 20131210 | Open filing evidence |
| 2010-07-01 – 2011-06-30 | 1226000000 | USD | 20131210 | Open filing evidence |
Dispensing Technologies · Medical Systems
Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ProductOrServiceAxis=cfn:DispensingTechnologiesMember;us-gaap:StatementBusinessSegmentsAxis=cfn:MedicalSystemsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2014-10-01 – 2014-12-31 | 264000000 | USD | 20150206 | Open filing evidence |
| 2014-07-01 – 2014-12-31 | 489000000 | USD | 20150206 | Open filing evidence |
| 2014-07-01 – 2014-09-30 | 225000000 | USD | 20141107 | Open filing evidence |
| 2013-07-01 – 2014-06-30 | 954000000 | USD | 20140811 | Open filing evidence |
| 2014-01-01 – 2014-03-31 | 233000000 | USD | 20140506 | Open filing evidence |
| 2013-07-01 – 2014-03-31 | 680000000 | USD | 20140506 | Open filing evidence |
| 2013-10-01 – 2013-12-31 | 236000000 | USD | 20150206 | Open filing evidence |
| 2013-07-01 – 2013-12-31 | 447000000 | USD | 20150206 | Open filing evidence |
| 2013-07-01 – 2013-09-30 | 211000000 | USD | 20141107 | Open filing evidence |
| 2012-07-01 – 2013-06-30 | 993000000 | USD | 20140811 | Open filing evidence |
| 2013-01-01 – 2013-03-31 | 234000000 | USD | 20140506 | Open filing evidence |
| 2012-07-01 – 2013-03-31 | 738000000 | USD | 20140506 | Open filing evidence |
| 2012-10-01 – 2012-12-31 | 260000000 | USD | 20140206 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 244000000 | USD | 20131108 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 1038000000 | USD | 20140811 | Open filing evidence |
Infection Prevention · Procedural Solutions
Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ProductOrServiceAxis=cfn:InfectionPreventionMember;us-gaap:StatementBusinessSegmentsAxis=cfn:ProceduralSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2014-10-01 – 2014-12-31 | 180000000 | USD | 20150206 | Open filing evidence |
| 2014-07-01 – 2014-12-31 | 347000000 | USD | 20150206 | Open filing evidence |
| 2014-07-01 – 2014-09-30 | 167000000 | USD | 20141107 | Open filing evidence |
| 2013-07-01 – 2014-06-30 | 656000000 | USD | 20140811 | Open filing evidence |
| 2014-01-01 – 2014-03-31 | 168000000 | USD | 20140506 | Open filing evidence |
| 2013-07-01 – 2014-03-31 | 485000000 | USD | 20140506 | Open filing evidence |
| 2013-10-01 – 2013-12-31 | 168000000 | USD | 20150206 | Open filing evidence |
| 2013-07-01 – 2013-12-31 | 317000000 | USD | 20150206 | Open filing evidence |
| 2013-07-01 – 2013-09-30 | 149000000 | USD | 20141107 | Open filing evidence |
| 2012-07-01 – 2013-06-30 | 594000000 | USD | 20140811 | Open filing evidence |
| 2013-01-01 – 2013-03-31 | 150000000 | USD | 20140506 | Open filing evidence |
| 2012-07-01 – 2013-03-31 | 446000000 | USD | 20140506 | Open filing evidence |
| 2012-10-01 – 2012-12-31 | 152000000 | USD | 20140206 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 144000000 | USD | 20131108 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 576000000 | USD | 20140811 | Open filing evidence |
Infusion Systems · Medical Systems
Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ProductOrServiceAxis=cfn:InfusionSystemsMember;us-gaap:StatementBusinessSegmentsAxis=cfn:MedicalSystemsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2014-10-01 – 2014-12-31 | 269000000 | USD | 20150206 | Open filing evidence |
| 2014-07-01 – 2014-12-31 | 482000000 | USD | 20150206 | Open filing evidence |
| 2014-07-01 – 2014-09-30 | 213000000 | USD | 20141107 | Open filing evidence |
| 2013-07-01 – 2014-06-30 | 1037000000 | USD | 20140811 | Open filing evidence |
| 2014-01-01 – 2014-03-31 | 238000000 | USD | 20140506 | Open filing evidence |
| 2013-07-01 – 2014-03-31 | 704000000 | USD | 20140506 | Open filing evidence |
| 2013-10-01 – 2013-12-31 | 247000000 | USD | 20150206 | Open filing evidence |
| 2013-07-01 – 2013-12-31 | 466000000 | USD | 20150206 | Open filing evidence |
| 2013-07-01 – 2013-09-30 | 219000000 | USD | 20141107 | Open filing evidence |
| 2012-07-01 – 2013-06-30 | 916000000 | USD | 20140811 | Open filing evidence |
| 2013-01-01 – 2013-03-31 | 246000000 | USD | 20140506 | Open filing evidence |
| 2012-07-01 – 2013-03-31 | 678000000 | USD | 20140506 | Open filing evidence |
| 2012-10-01 – 2012-12-31 | 229000000 | USD | 20140206 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 203000000 | USD | 20131108 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 955000000 | USD | 20140811 | Open filing evidence |
Medical Specialties · Procedural Solutions
Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ProductOrServiceAxis=cfn:MedicalSpecialtiesMember;us-gaap:StatementBusinessSegmentsAxis=cfn:ProceduralSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2014-10-01 – 2014-12-31 | 96000000 | USD | 20150206 | Open filing evidence |
| 2014-07-01 – 2014-12-31 | 187000000 | USD | 20150206 | Open filing evidence |
| 2014-07-01 – 2014-09-30 | 91000000 | USD | 20141107 | Open filing evidence |
| 2013-07-01 – 2014-06-30 | 364000000 | USD | 20140811 | Open filing evidence |
| 2014-01-01 – 2014-03-31 | 91000000 | USD | 20140506 | Open filing evidence |
| 2013-07-01 – 2014-03-31 | 269000000 | USD | 20140506 | Open filing evidence |
| 2013-10-01 – 2013-12-31 | 89000000 | USD | 20150206 | Open filing evidence |
| 2013-07-01 – 2013-12-31 | 178000000 | USD | 20150206 | Open filing evidence |
| 2013-07-01 – 2013-09-30 | 89000000 | USD | 20141107 | Open filing evidence |
| 2012-07-01 – 2013-06-30 | 344000000 | USD | 20140811 | Open filing evidence |
| 2013-01-01 – 2013-03-31 | 88000000 | USD | 20140506 | Open filing evidence |
| 2012-07-01 – 2013-03-31 | 254000000 | USD | 20140506 | Open filing evidence |
| 2012-10-01 – 2012-12-31 | 86000000 | USD | 20140206 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 80000000 | USD | 20131108 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 317000000 | USD | 20140811 | Open filing evidence |
Other Medical Systems · Medical Systems
Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ProductOrServiceAxis=cfn:OtherMedicalSystemsMember;us-gaap:StatementBusinessSegmentsAxis=cfn:MedicalSystemsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2014-10-01 – 2014-12-31 | 6000000 | USD | 20150206 | Open filing evidence |
| 2014-07-01 – 2014-12-31 | 11000000 | USD | 20150206 | Open filing evidence |
| 2014-07-01 – 2014-09-30 | 5000000 | USD | 20141107 | Open filing evidence |
| 2013-07-01 – 2014-06-30 | 26000000 | USD | 20140811 | Open filing evidence |
| 2014-01-01 – 2014-03-31 | 6000000 | USD | 20140506 | Open filing evidence |
| 2013-07-01 – 2014-03-31 | 20000000 | USD | 20140506 | Open filing evidence |
| 2013-10-01 – 2013-12-31 | 8000000 | USD | 20150206 | Open filing evidence |
| 2013-07-01 – 2013-12-31 | 14000000 | USD | 20150206 | Open filing evidence |
| 2013-07-01 – 2013-09-30 | 6000000 | USD | 20141107 | Open filing evidence |
| 2012-07-01 – 2013-06-30 | 27000000 | USD | 20140811 | Open filing evidence |
| 2013-01-01 – 2013-03-31 | 7000000 | USD | 20140506 | Open filing evidence |
| 2012-07-01 – 2013-03-31 | 21000000 | USD | 20140506 | Open filing evidence |
| 2012-10-01 – 2012-12-31 | 7000000 | USD | 20140206 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 7000000 | USD | 20131108 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 26000000 | USD | 20140811 | Open filing evidence |
Respiratory Technologies · Medical Systems
Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ProductOrServiceAxis=cfn:RespiratoryTechnologiesMember;us-gaap:StatementBusinessSegmentsAxis=cfn:MedicalSystemsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2014-10-01 – 2014-12-31 | 106000000 | USD | 20150206 | Open filing evidence |
| 2014-07-01 – 2014-12-31 | 191000000 | USD | 20150206 | Open filing evidence |
| 2014-07-01 – 2014-09-30 | 85000000 | USD | 20141107 | Open filing evidence |
| 2013-07-01 – 2014-06-30 | 377000000 | USD | 20140811 | Open filing evidence |
| 2014-01-01 – 2014-03-31 | 94000000 | USD | 20140506 | Open filing evidence |
| 2013-07-01 – 2014-03-31 | 278000000 | USD | 20140506 | Open filing evidence |
| 2013-10-01 – 2013-12-31 | 96000000 | USD | 20150206 | Open filing evidence |
| 2013-07-01 – 2013-12-31 | 184000000 | USD | 20150206 | Open filing evidence |
| 2013-07-01 – 2013-09-30 | 88000000 | USD | 20141107 | Open filing evidence |
| 2012-07-01 – 2013-06-30 | 393000000 | USD | 20140811 | Open filing evidence |
| 2013-01-01 – 2013-03-31 | 97000000 | USD | 20140506 | Open filing evidence |
| 2012-07-01 – 2013-03-31 | 300000000 | USD | 20140506 | Open filing evidence |
| 2012-10-01 – 2012-12-31 | 106000000 | USD | 20140206 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 97000000 | USD | 20131108 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 420000000 | USD | 20140811 | Open filing evidence |
Specialty Disposables · Procedural Solutions
Product Or Service · Statement Business Segments
Source dimensions
us-gaap:ProductOrServiceAxis=cfn:SpecialtyDisposablesMember;us-gaap:StatementBusinessSegmentsAxis=cfn:ProceduralSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2014-10-01 – 2014-12-31 | 148000000 | USD | 20150206 | Open filing evidence |
| 2014-07-01 – 2014-12-31 | 284000000 | USD | 20150206 | Open filing evidence |
| 2014-07-01 – 2014-09-30 | 136000000 | USD | 20141107 | Open filing evidence |
| 2013-07-01 – 2014-06-30 | 428000000 | USD | 20140811 | Open filing evidence |
| 2014-01-01 – 2014-03-31 | 138000000 | USD | 20140506 | Open filing evidence |
| 2013-07-01 – 2014-03-31 | 284000000 | USD | 20140506 | Open filing evidence |
| 2013-10-01 – 2013-12-31 | 78000000 | USD | 20150206 | Open filing evidence |
| 2013-07-01 – 2013-12-31 | 146000000 | USD | 20150206 | Open filing evidence |
| 2013-07-01 – 2013-09-30 | 68000000 | USD | 20141107 | Open filing evidence |
| 2012-07-01 – 2013-06-30 | 283000000 | USD | 20140811 | Open filing evidence |
| 2013-01-01 – 2013-03-31 | 79000000 | USD | 20140506 | Open filing evidence |
| 2012-07-01 – 2013-03-31 | 210000000 | USD | 20140506 | Open filing evidence |
| 2012-10-01 – 2012-12-31 | 69000000 | USD | 20140206 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 62000000 | USD | 20131108 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 266000000 | USD | 20140811 | Open filing evidence |
International
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cfn:InternationalMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2013-07-01 – 2014-06-30 | 886000000 | USD | 20140811 | Open filing evidence |
| 2012-07-01 – 2013-06-30 | 769000000 | USD | 20140811 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 790000000 | USD | 20140811 | Open filing evidence |
| 2010-07-01 – 2011-06-30 | 664000000 | USD | 20130809 | Open filing evidence |
Medical Systems
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cfn:MedicalSystemsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2014-10-01 – 2014-12-31 | 645000000 | USD | 20150206 | Open filing evidence |
| 2014-07-01 – 2014-12-31 | 1173000000 | USD | 20150206 | Open filing evidence |
| 2014-07-01 – 2014-09-30 | 528000000 | USD | 20141107 | Open filing evidence |
| 2013-07-01 – 2014-06-30 | 2394000000 | USD | 20140811 | Open filing evidence |
| 2014-01-01 – 2014-03-31 | 571000000 | USD | 20140506 | Open filing evidence |
| 2013-07-01 – 2014-03-31 | 1682000000 | USD | 20140506 | Open filing evidence |
| 2013-10-01 – 2013-12-31 | 587000000 | USD | 20150206 | Open filing evidence |
| 2013-07-01 – 2013-12-31 | 1111000000 | USD | 20150206 | Open filing evidence |
| 2013-07-01 – 2013-09-30 | 524000000 | USD | 20141107 | Open filing evidence |
| 2012-07-01 – 2013-06-30 | 2329000000 | USD | 20140811 | Open filing evidence |
| 2013-01-01 – 2013-03-31 | 584000000 | USD | 20140506 | Open filing evidence |
| 2012-07-01 – 2013-03-31 | 1737000000 | USD | 20140506 | Open filing evidence |
| 2012-10-01 – 2012-12-31 | 602000000 | USD | 20140206 | Open filing evidence |
| 2012-07-01 – 2012-12-31 | 1153000000 | USD | 20140206 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 551000000 | USD | 20131210 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 2439000000 Restated | USD | 20140811 | Open filing evidence |
| 2012-01-01 – 2012-03-31 | 619000000 Restated | USD | 20130510 | Open filing evidence |
| 2011-07-01 – 2012-03-31 | 1769000000 Restated | USD | 20130510 | Open filing evidence |
| 2011-10-01 – 2011-12-31 | 604000000 Restated | USD | 20130208 | Open filing evidence |
| 2011-07-01 – 2011-12-31 | 1150000000 Restated | USD | 20130208 | Open filing evidence |
| 2011-07-01 – 2011-09-30 | 546000000 Restated | USD | 20130208 | Open filing evidence |
| 2010-07-01 – 2011-06-30 | 2214000000 Restated | USD | 20131210 | Open filing evidence |
| 2011-01-01 – 2011-03-31 | 498000000 | USD | 20120504 | Open filing evidence |
| 2010-07-01 – 2011-03-31 | 1489000000 | USD | 20120504 | Open filing evidence |
| 2010-10-01 – 2010-12-31 | 523000000 | USD | 20120203 | Open filing evidence |
| 2010-07-01 – 2010-12-31 | 991000000 | USD | 20120203 | Open filing evidence |
| 2010-07-01 – 2010-09-30 | 468000000 | USD | 20111108 | Open filing evidence |
| 2009-07-01 – 2010-06-30 | 2071000000 | USD | 20130131 | Open filing evidence |
Procedural Solutions
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cfn:ProceduralSolutionsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2014-10-01 – 2014-12-31 | 424000000 | USD | 20150206 | Open filing evidence |
| 2014-07-01 – 2014-12-31 | 818000000 | USD | 20150206 | Open filing evidence |
| 2014-07-01 – 2014-09-30 | 394000000 | USD | 20141107 | Open filing evidence |
| 2013-07-01 – 2014-06-30 | 1448000000 | USD | 20140811 | Open filing evidence |
| 2014-01-01 – 2014-03-31 | 397000000 | USD | 20140506 | Open filing evidence |
| 2013-07-01 – 2014-03-31 | 1038000000 | USD | 20140506 | Open filing evidence |
| 2013-10-01 – 2013-12-31 | 335000000 | USD | 20150206 | Open filing evidence |
| 2013-07-01 – 2013-12-31 | 641000000 | USD | 20150206 | Open filing evidence |
| 2013-07-01 – 2013-09-30 | 306000000 | USD | 20141107 | Open filing evidence |
| 2012-07-01 – 2013-06-30 | 1221000000 | USD | 20140811 | Open filing evidence |
| 2013-01-01 – 2013-03-31 | 317000000 | USD | 20140506 | Open filing evidence |
| 2012-07-01 – 2013-03-31 | 910000000 | USD | 20140506 | Open filing evidence |
| 2012-10-01 – 2012-12-31 | 307000000 | USD | 20140206 | Open filing evidence |
| 2012-07-01 – 2012-12-31 | 593000000 | USD | 20140206 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 286000000 | USD | 20131210 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 1159000000 Restated | USD | 20140811 | Open filing evidence |
| 2012-01-01 – 2012-03-31 | 300000000 Restated | USD | 20130510 | Open filing evidence |
| 2011-07-01 – 2012-03-31 | 868000000 Restated | USD | 20130510 | Open filing evidence |
| 2011-10-01 – 2011-12-31 | 286000000 Restated | USD | 20130208 | Open filing evidence |
| 2011-07-01 – 2011-12-31 | 568000000 Restated | USD | 20130208 | Open filing evidence |
| 2011-07-01 – 2011-09-30 | 282000000 Restated | USD | 20130208 | Open filing evidence |
| 2010-07-01 – 2011-06-30 | 1226000000 Restated | USD | 20131210 | Open filing evidence |
| 2011-01-01 – 2011-03-31 | 344000000 | USD | 20120504 | Open filing evidence |
| 2010-07-01 – 2011-03-31 | 1003000000 | USD | 20120504 | Open filing evidence |
| 2010-10-01 – 2010-12-31 | 363000000 | USD | 20120203 | Open filing evidence |
| 2010-07-01 – 2010-12-31 | 706000000 | USD | 20120203 | Open filing evidence |
| 2010-07-01 – 2010-09-30 | 343000000 | USD | 20111108 | Open filing evidence |
| 2009-07-01 – 2010-06-30 | 1306000000 | USD | 20130131 | Open filing evidence |
United States
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=cfn:UnitedStatesMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2012-07-01 – 2013-06-30 | 2781000000 | USD | 20130809 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 2808000000 | USD | 20130809 | Open filing evidence |
| 2010-07-01 – 2011-06-30 | 2776000000 | USD | 20130809 | Open filing evidence |
US
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=country:US| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2013-07-01 – 2014-06-30 | 2956000000 | USD | 20140811 | Open filing evidence |
| 2012-07-01 – 2013-06-30 | 2781000000 | USD | 20140811 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 2808000000 | USD | 20140811 | Open filing evidence |
Operating Segments
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2014-10-01 – 2014-12-31 | 1069000000 | USD | 20150206 | Open filing evidence |
| 2014-07-01 – 2014-12-31 | 1991000000 | USD | 20150206 | Open filing evidence |
| 2014-07-01 – 2014-09-30 | 922000000 | USD | 20141107 | Open filing evidence |
| 2013-07-01 – 2014-06-30 | 3842000000 | USD | 20140811 | Open filing evidence |
| 2014-01-01 – 2014-03-31 | 968000000 | USD | 20140506 | Open filing evidence |
| 2013-07-01 – 2014-03-31 | 2720000000 | USD | 20140506 | Open filing evidence |
| 2013-10-01 – 2013-12-31 | 922000000 | USD | 20150206 | Open filing evidence |
| 2013-07-01 – 2013-12-31 | 1752000000 | USD | 20150206 | Open filing evidence |
| 2013-07-01 – 2013-09-30 | 830000000 | USD | 20141107 | Open filing evidence |
| 2012-07-01 – 2013-06-30 | 3550000000 | USD | 20140811 | Open filing evidence |
| 2013-01-01 – 2013-03-31 | 901000000 | USD | 20140506 | Open filing evidence |
| 2012-07-01 – 2013-03-31 | 2647000000 | USD | 20140506 | Open filing evidence |
| 2012-10-01 – 2012-12-31 | 909000000 | USD | 20140206 | Open filing evidence |
| 2012-07-01 – 2012-12-31 | 1746000000 | USD | 20140206 | Open filing evidence |
| 2012-07-01 – 2012-09-30 | 837000000 | USD | 20131210 | Open filing evidence |
| 2011-07-01 – 2012-06-30 | 3598000000 | USD | 20140811 | Open filing evidence |